Showing Latest Articles
Respiratory Syncytial Virus Infection in Adults
Seminars in Respiratory and Critical Care Medicine, 08/24/2011
Walsh EE – Specific antiviral therapy is generally reserved for severely immunocompromised patients or severe respiratory failure. The greatest promise for reducing the impact of Respiratory syncytial virus (RSV) in adults may be through immunization. However, an effective vaccine for RSV is not currently available.